Abstract | OBJECTIVES: METHODS: A retrospective study involving all women treated with pulsatile GnRH, over a 3-year period, in 24 French centers. Pregnancy rate and pregnancy outcome were the criteria for evaluation. RESULTS: The study included 248 women who received a total of 829 treatment cycles. The treatment routes of administration were subcutaneous (56.1% of the patients), intravenous (31.1%), or both (12.7%). The pregnancy rate per treatment cycle was 25%, while the mean number of cycles needed to obtain a pregnancy was 2.8+/-1.7. The miscarriage rate was 8.2% and the multiple pregnancy rates 8.8%. The mean delivery term was 38.4+/-2.4 weeks and the mean birth weight was 3009+/-561 g. No severe ovarian hyperstimulation was recorded. Ovarian cysts occurred in 2.3% of the treatment cycles, local allergies in 1.7%. CONCLUSION: Our study has shown that pulsatile GnRH treatment was well tolerated, without severe hyperstimulation. It induced a good pregnancy rate with favorable pregnancy outcomes.
|
Authors | S Christin-Maitre, M de Crécy, Groupe Français des pompes à GnRH |
Journal | Journal de gynecologie, obstetrique et biologie de la reproduction
(J Gynecol Obstet Biol Reprod (Paris))
Vol. 36
Issue 1
Pg. 8-12
(Feb 2007)
ISSN: 0368-2315 [Print] France |
Vernacular Title | Grossesses obtenues par administration pulsatile de GnRH: résultats d'une large étude rétrospective multicentrique. |
PMID | 17293247
(Publication Type: English Abstract, Journal Article, Multicenter Study)
|
Chemical References |
- Fertility Agents, Female
- Gonadotropin-Releasing Hormone
|
Topics |
- Administration, Cutaneous
- Adult
- Cohort Studies
- Female
- Fertility Agents, Female
(administration & dosage)
- Gonadotropin-Releasing Hormone
(administration & dosage)
- Humans
- Hypogonadism
(complications)
- Injections, Intravenous
- Pregnancy
- Pregnancy Outcome
- Pregnancy Rate
- Retrospective Studies
|